Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Prostate Cancer

Free Subscription Articles published in Cancer Imaging Retrieve available abstracts of 11 articles: HTML format

Single Articles

July 2022
1. ZHANG YN, Lu ZG, Wang SD, Lu X, et al
   Gross tumor volume delineation in primary prostate cancer on (18)F-PSMA-1007 PET/MRI and (68)Ga-PSMA-11 PET/MRI.
   Cancer Imaging. 2022;22:36.
   PubMed     Abstract available
   
   
   
2. RUCHALSKI K, Kim HJ, Douek M, Raman S, et al
   Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression.
   Cancer Imaging. 2022;22:34.
   PubMed     Abstract available
   
   
   April 2022
3. CHEN Z, Chen X, Wang R
   Application of SPECT and PET / CT with computer-aided diagnosis in bone metastasis of prostate cancer: a review.
   Cancer Imaging. 2022;22:18.
   PubMed     Abstract available
   
   
   March 2022
4. LEWIS S, Ganti A, Argiriadi P, Rosen A, et al
   Prostate MRI using a rigid two-channel phased-array endorectal coil: comparison with phased array coil acquisition at 3 T.
   Cancer Imaging. 2022;22:15.
   PubMed     Abstract available
   
   
   September 2021
5. XING P, Chen L, Yang Q, Song T, et al
   Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging.
   Cancer Imaging. 2021;21:54.
   PubMed     Abstract available
   
   
   July 2021
6. HE D, Wang X, Fu C, Wei X, et al
   MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins.
   Cancer Imaging. 2021;21:46.
   PubMed     Abstract available
   
   
   April 2021
7. OSMAN MM, Iravani A, Hofman MS, Hicks RJ, et al
   Intra-patient comparison of physiologic (68)Ga-PSMA-11 and (18)F-DCFPyL PET/CT uptake in ganglia in prostate cancer patients: a pictorial essay.
   Cancer Imaging. 2021;21:35.
   PubMed     Abstract available
   
   
   January 2021
8. VENKATESAN AM, Mudairu-Dawodu E, Duran C, Stafford RJ, et al
   Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade.
   Cancer Imaging. 2021;21:3.
   PubMed     Abstract available
   
   
   October 2020
9. PRICOLO P, Ancona E, Summers P, Abreu-Gomez J, et al
   Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.
   Cancer Imaging. 2020;20:77.
   PubMed     Abstract available
   
   
   
10. HIETIKKO R, Kilpelainen TP, Kenttamies A, Ronkainen J, et al
    Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study.
    Cancer Imaging. 2020;20:72.
    PubMed     Abstract available
    
    
    August 2020
11. DE LEIRIS N, Leenhardt J, Boussat B, Montemagno C, et al
    Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
    Cancer Imaging. 2020;20:58.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: